Key result
Oncostatin M acts as a secreted niche factor that induces reversible muscle stem cell quiescence and maintains stem cell regenerative capacity.
Oncostatin M acts as a secreted niche factor that induces reversible quiescence and maintains the regenerative capacity of skeletal muscle stem cells.
The balance between stem cell quiescence and proliferation in skeletal muscle is tightly controlled, but perturbed in a variety of disease states. Despite progress in identifying activators of stem cell proliferation, the niche factor(s) responsible for quiescence induction remain unclear. Here we report an in vivo imaging-based screen which identifies Oncostatin M (OSM), a member of the interleukin-6 family of cytokines, as a potent inducer of muscle stem cell (MuSC, satellite cell) quiescence. OSM is produced by muscle fibers, induces reversible MuSC cell cycle exit, and maintains stem cell regenerative capacity as judged by serial transplantation. Conditional OSM receptor deletion in satellite cells leads to stem cell depletion and impaired regeneration following injury. These results identify Oncostatin M as a secreted niche factor responsible for quiescence induction, and for the first time establish a direct connection between induction of quiescence, stemness, and transplantation potential in solid organ stem cells.
No takes yet. Share an insight, caveat, or question.
Sampath et al. (2018) studied Muscle stem cell quiescence and regeneration. Oncostatin M (OSM) vs. Conditional OSM receptor deletion was evaluated on Muscle stem cell quiescence induction and regenerative capacity. Oncostatin M acts as a secreted niche factor that induces reversible muscle stem cell quiescence and maintains stem cell regenerative capacity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: